Ptc Therapeutics (PTCT) Shares Outstanding (Diluted Average) (2019 - 2024)

Ptc Therapeutics' Shares Outstanding (Diluted Average) history runs 6 years deep, the most recent figure standing at $76.8 million for Q4 2024.

• In Q4 2024, Shares Outstanding (Diluted Average) rose 2.68% year-over-year to $76.8 million; the TTM figure through Dec 2024 stood at $76.8 million (up 2.68% YoY), while the FY2024 annual figure was $76.8 million, up 2.68% from the prior year.
• Shares Outstanding (Diluted Average) was $76.8 million for Q4 2024 at Ptc Therapeutics, roughly flat from $76.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $76.9 million in Q3 2024 to a low of $66.0 million in Q4 2020.
• Historically, Shares Outstanding (Diluted Average) has averaged $72.9 million across 5 years, with a median of $71.7 million in 2022.
• The sharpest annual moves came in 2020 and 2022: Shares Outstanding (Diluted Average) gained 12.17% in 2020, then advanced 1.36% in 2022.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $66.0 million in 2020, then increased by 6.72% to $70.5 million in 2021, then climbed by 1.79% to $71.7 million in 2022, then rose by 4.34% to $74.8 million in 2023, then advanced by 2.68% to $76.8 million in 2024.
• The last three Shares Outstanding (Diluted Average) figures came in at $76.8 million (Q4 2024), $76.9 million (Q3 2024), and $76.7 million (Q2 2024), per Business Quant data.